Meet the DM Drug Developers: Dyne Therapeutics

Meet the DM Drug Developers: Dyne’s Approach to Targeting DM1
February 5th, 2021
12:00 PM Pacific

Each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions. Click here to learn more about Dyne Therapeutics.

Presenters will include Josh Brumm, Chief Executive Officer; Romesh Subramanian, PhD, Chief Scientific Officer; Chris Mix, MD, Senior Vice President, Clinical Development; and Molly White, Vice President, Medical Communications & Advocacy.

Click here to find all our upcoming Meet the DM Drug Developers dates!

Date(s)

Fri, 02/05/2021 - 04:00AM Add to Calendar 2021-02-05 00:00:00 2021-02-05 00:00:00 Meet the DM Drug Developers: Dyne Therapeutics To know more about this Event, Just go to: https://www.myotonic.org/meet-dm-drug-developers-dyne-therapeutics Location Myotonic Dystrophy Foundation info@myotonic.org America/Vancouver public

Myotonic Dystrophy News

April 2,2024

Participants Needed for Important DM Research Study

The Myotonic Dystrophy Clinical Research Network (DMCRN) sites are currently conducting a critica

March 29,2024

Request for Applications Open - 2025 MDF Research Fellowships & Grants!

We are thrilled to announce the upcoming launch in April of four grant programs aimed at accelerating research efforts to improve the lives of individuals affected by myotonic dystrophy and pave the way toward finding effective treatments and ultimately a cure for this challenging condition. There are multiple fantastic opportunities available - learn more below & get ready to apply!

March 29,2024

Meet the Early Career Grant Recipient: Dr. Johanna Hamel

Dr. Johanna Hamel, an Assistant Professor in Neurology, Pathology, and Laboratory Medicine, developed her interest in DM1 and DM2 during medical school in Germany. Her residency at the University of Rochester, chosen for its focus on neuromuscular medicine and DM, led to a fellowship under Dr. Charles Thornton, funded by the Clinical Research Training Fellowship Award in Muscular Dystrophy.

March 20,2024

Meet the DM Drug Developers

Leading up to and after the 2024 MDF Regional Conferences in the spring, our biotechnology and pharmaceutical partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions in real time.

February 14,2024

Research Fellow Feature: Cameron Niazi

After spending two years at Vertex Pharmaceuticals, Cameron Niazi pursued a Ph.D. at the University of Florida in Dr. Eric Wang's lab. Attracted by the lab's integration of basic science and translational research, joining the Wang Lab also provided a personal connection to DM1.

Questions?

Request Warmline Support! MDF offers a professionally staffed Warmline for people living with myotonic dystrophy, their caregivers, medical professionals and others to ask questions, find support and guidance and, when appropriate, be connected to additional resources and services. Click here to request Warmline Support.

Additional questions? Contact MDF by email at info@myotonic.org or give us a call at 415-800-7777.

Meet the DM Drug Developers: Dyne’s Approach to Targeting DM1 February 5th, 2021 12:00 PM Pacific

Meet the DM Drug Developers: Dyne’s Approach to Targeting DM1
February 5th, 2021
12:00 PM Pacific